Koroleva, Anna
Novo Nordisk (Denmark)
3 papers on CoChatORCID 0000-0003-2655-1284
Most cited papers
- Verified
Effect of Subcutaneous Semaglutide vs Placebo as an Adjunct to Intensive Behavioral Therapy on Body Weight in Adults With Overweight or Obesity: The STEP 3 Randomized Clinical Trial
Wadden, T. A., Bailey, T. S., Billings, L. K., Davies, M., Frias, J. P., Koroleva, A., Lingvay, I., O’Neil, P. M., Rubino, D. M., Skovgaard, D., et al. (2021) · JAMA
Pharmacology and Obesity TreatmentDiabetes Treatment and Management
Cited by 1,114
- Verified
Once-Weekly Semaglutide in Persons with Obesity and Knee Osteoarthritis
Bliddal, H., Bays, H., Czernichow, S., Uddén Hemmingsson, J., Hjelmesæth, J., Hoffmann Morville, T., Koroleva, A., Skov Neergaard, J., Vélez Sánchez, P., Wharton, S., et al. (2024) · New England Journal of Medicine
Osteoarthritis Treatment and MechanismsPharmacology and Obesity Treatment
Cited by 440
- Verified
Anti-obesity treatment preferences of healthcare providers and people living with obesity: A survey-based study
Le Roux, C. W., Koroleva, A., Larsen, S., & Foot, E. (2025) · Clinical Obesity
Pharmacology and Obesity TreatmentObesity and Health Practices
Cited by 11
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free